English
Polski
Español
українська
Treatment of asthma: Predicting the future of atopic disease treatment
Prof. Paul O’Byrne shares his predictions for developments in the treatment of atopic diseases.
2016-08-17
Prof. Paul O’Byrne shares his predictions for developments in the treatment of atopic diseases.
Prof. Paul O’Byrne explains the roles of different types of drugs used in asthma treatment.
Prof. Paul O’Byrne summarizes new information about the safety of long-acting ß2-agonists in asthma treatment.
Prof. Paul O’Byrne talks about the history of long-acting ß2-agonists in asthma treatment.
Prof. Andreas Freitag looks back at the evolution of treatment for cystic fibrosis and shares his predictions for gene therapy.
Prof. Mark Crowther talks about drugs used in thromboembolism treatment and emerging challenges in the field.
Prof. Hertzel Gerstein guides us through agents used in diabetes and reviews 2015 developments in the field.
Prof. Mark Crowther discusses recent milestones in the development of thromboembolism treatment.
Prof. Waleed Alhazzani shares his views on stress ulcer prophylaxis in critically ill patients.
Prof. Mark Crowther looks back at 2015 highlights in hematology and thromboembolism.
